Prolight Diagnostics AB (publ) publishes annual report for 2025

PRLDRegulatoriskt pressmeddelande05.05.2026 klo 16.30

Prolight Diagnostics AB (publ) has today published its Annual Report for the financial year 2025. The report is available via the attached file or on the Company’s website: https://prolightdx.com/en/investors/financial-reports/

About Us
Prolight Diagnostics AB develops innovative Point-of-Care systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of high sensitive troponin, to aid in the rule-in and rule-out of myocardial infarction.

The company’s share is traded on the NGM Growth Market marketplace, under the ticker PRLD.